Failure of guanidine therapy in botulism A.
D000200:Action Potentials; D000328:Adult; D000992:Antitoxins / Q000627:therapeutic use; D001905:Botulinum Toxins / Q000037:antagonists & inhibitors; D001906:Botulism / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D002648:Child; D004576:Electromyography; D005260:Female; D006146:Guanidines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000503:physiopathology; D013997:Time Factors; D014797:Vital Capacity
D000992:Antitoxins; D006146:Guanidines; D001905:Botulinum Toxins